🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Diamond Biofund Inc. (TPE:6901)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.85
-0.95 (-6.88%)
Nov 19, 2026, 1:30 PM CST

Diamond Biofund Statistics

Total Valuation

Diamond Biofund has a market cap or net worth of TWD 10.97 billion. The enterprise value is 4.44 billion.

Market Cap10.97B
Enterprise Value 4.44B

Important Dates

The last earnings date was Monday, August 10, 2026.

Earnings Date Aug 10, 2026
Ex-Dividend Date n/a

Share Statistics

Diamond Biofund has 853.36 million shares outstanding. The number of shares has increased by 1.62% in one year.

Current Share Class 853.36M
Shares Outstanding 853.36M
Shares Change (YoY) +1.62%
Shares Change (QoQ) -1.29%
Owned by Insiders (%) 25.00%
Owned by Institutions (%) 4.41%
Float 177.01M

Valuation Ratios

The trailing PE ratio is 4.54.

PE Ratio 4.54
Forward PE n/a
PS Ratio 4.28
PB Ratio 0.94
P/TBV Ratio 0.94
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 1.81
EV / Sales 1.73
EV / EBITDA 1.82
EV / EBIT 1.84
EV / FCF n/a

Financial Position

The company has a current ratio of 86.18, with a Debt / Equity ratio of 0.01.

Current Ratio 86.18
Quick Ratio 86.14
Debt / Equity 0.01
Debt / EBITDA 0.03
Debt / FCF n/a
Interest Coverage 977.97

Financial Efficiency

Return on equity (ROE) is 23.42% and return on invested capital (ROIC) is 46.69%.

Return on Equity (ROE) 23.42%
Return on Assets (ROA) 14.22%
Return on Invested Capital (ROIC) 46.69%
Return on Capital Employed (ROCE) 20.54%
Weighted Average Cost of Capital (WACC) 9.15%
Revenue Per Employee 88.33M
Profits Per Employee 84.48M
Employee Count29
Asset Turnover 0.24
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -23.05% in the last 52 weeks. The beta is 0.90, so Diamond Biofund's price volatility has been lower than the market average.

Beta (5Y) 0.90
52-Week Price Change -23.05%
50-Day Moving Average 15.76
200-Day Moving Average 15.78
Relative Strength Index (RSI) 26.02
Average Volume (20 Days) 1,465,035

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Diamond Biofund had revenue of TWD 2.56 billion and earned 2.45 billion in profits. Earnings per share was 2.83.

Revenue2.56B
Gross Profit 2.56B
Operating Income 2.41B
Pretax Income 2.45B
Net Income 2.45B
EBITDA 2.42B
EBIT 2.41B
Earnings Per Share (EPS) 2.83
Full Income Statement

Balance Sheet

The company has 6.60 billion in cash and 75.54 million in debt, with a net cash position of 6.53 billion or 7.65 per share.

Cash & Cash Equivalents 6.60B
Total Debt 75.54M
Net Cash 6.53B
Net Cash Per Share 7.65
Equity (Book Value) 11.70B
Book Value Per Share 13.63
Working Capital 6.55B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -577.81 million and capital expenditures -1,000, giving a free cash flow of -577.81 million.

Operating Cash Flow -577.81M
Capital Expenditures -1,000
Depreciation & Amortization 5.43M
Net Borrowing -24.44M
Free Cash Flow -577.81M
FCF Per Share -0.68
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 94.22% and 95.64%.

Gross Margin 100.00%
Operating Margin 94.22%
Pretax Margin 95.64%
Profit Margin 95.64%
EBITDA Margin 94.43%
EBIT Margin 94.22%
FCF Margin n/a

Dividends & Yields

Diamond Biofund does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -1.62%
Shareholder Yield -1.62%
Earnings Yield 22.02%
FCF Yield -5.27%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.

Last Split Date Aug 7, 2023
Split Type Forward
Split Ratio 1.18

Scores

Diamond Biofund has an Altman Z-Score of 66.93 and a Piotroski F-Score of 3.

Altman Z-Score 66.93
Piotroski F-Score 3